The removal of advanced data from a popular internet resource has proven unpopular – The Athletic breaks down what happened ...
NotebookLM with Gemini 3 turn research into tools, from searchable dashboards to sites with filters, so you ship useful ...
The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...
These days, many Americans think they need over a million dollars to be able to retire comfortably. More specifically, they ...
The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...
Compare the best trading signals in the US for 2026. See top providers, costs, accuracy, and platforms for stocks, forex, and ...
Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with ...
Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...
Stock futures slid Sunday ahead of this week’s Fed rate decision and mounting fears of a second government shutdown in months, with Dow futures down 0.6%, S&P 500 off 0.7%, and Nasdaq futures lower by ...
Explore the top HIPAA compliance software solutions for healthcare and health tech companies in 2026. Compare features, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results